Angiodynamics Inc. logo

Angiodynamics Inc. (ANGO)

Market Closed
30 May, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
10. 20
+0.2
+2%
Pre Market
$
9. 45
-0.75 -7.35%
444.65M Market Cap
- P/E Ratio
0% Div Yield
911,500 Volume
-0.39 Eps
$ 10
Previous Close
Day Range
9.78 10.4
Year Range
5.47 13.5

Summary

ANGO closed Friday higher at $10.2, an increase of 2% from Thursday's close, completing a monthly increase of 10.03% or $0.93. Over the past 12 months, ANGO stock gained 10.75%.
ANGO is not paying dividends to its shareholders.
The last earnings report, released on Apr 02, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track ANGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

ANGO Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?

What Makes AngioDynamics (ANGO) a Strong Momentum Stock: Buy Now?

Does AngioDynamics (ANGO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 1 day ago
Wall Street Analysts See a 63.23% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?

Wall Street Analysts See a 63.23% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 63.2% in AngioDynamics (ANGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks | 1 month ago
Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?

Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year?

Here is how AngioDynamics (ANGO) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

Zacks | 1 month ago

Angiodynamics Inc. Dividends

ANGO is not paying dividends to its shareholders.

Angiodynamics Inc. Earnings

2 Apr 2025 Date
-
Cons. EPS
-
EPS
3 Jan 2025 Date
-
Cons. EPS
-
EPS
3 Oct 2024 Date
-
Cons. EPS
-
EPS
2 Oct 2024 Date
-
Cons. EPS
-
EPS
16 Jul 2024 Date
-
Cons. EPS
-
EPS
ANGO is not paying dividends to its shareholders.
2 Apr 2025 Date
-
Cons. EPS
-
EPS
3 Jan 2025 Date
-
Cons. EPS
-
EPS
3 Oct 2024 Date
-
Cons. EPS
-
EPS
2 Oct 2024 Date
-
Cons. EPS
-
EPS
16 Jul 2024 Date
-
Cons. EPS
-
EPS

Angiodynamics Inc. (ANGO) FAQ

What is the stock price today?

The current price is $10.20.

On which exchange is it traded?

Angiodynamics Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is ANGO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 444.65M.

Has Angiodynamics Inc. ever had a stock split?

No, there has never been a stock split.

Angiodynamics Inc. Profile

Medical - Instruments & Supplies Industry
Healthcare Sector
Mr. James C. Clemmer CEO
NASDAQ (NGS) Exchange
03475V101 Cusip
US Country
748 Employees
- Last Dividend
- Last Split
27 May 2004 IPO Date

Overview

AngioDynamics, Inc. is a prominent provider of invasive medical devices, catering to the needs of professional healthcare providers across the United States and internationally. The company specializes in a broad spectrum of medical areas, including vascular access, surgery, peripheral vascular disease, and oncology. Established in 1988, AngioDynamics is committed to enhancing patient outcomes through its innovative technologies and solutions, headquartered in Latham, New York.

Products and Services

  • Auryon Atherectomy System: A cutting-edge solution for the treatment of peripheral arterial disease. This system utilizes an optimized wavelength, pulse width, and amplitude to efficiently remove lesions while preserving the vessel wall endothelium.
  • Thrombus Management Portfolio:
    • AlphaVac System: A mechanical aspiration device designed for emergent situations, obviating the need for perfusionist support.
    • Thrombolytic Catheters: These are used to deliver drugs known as thrombolytic agents, intended to dissolve blood clots found in hemodialysis access grafts, arteries, veins, and surgical bypass grafts.
    • AngioVac Circuit: Designed for extracorporeal circulatory support for up to six hours. This includes a pump, filter, and reinfusion cannula to facilitate venous drainage during bypass procedures.
  • NanoKnife IRE Ablation System: Offers a non-traditional thermal approach for the surgical ablation of soft tissue, providing an alternative to conventional methods.
  • Peripheral Products: This category includes a range of products such as angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. These are essential tools for peripheral diagnostic and interventional procedures.
  • Drainage Catheters: A diverse range of catheters for various purposes, including multi-purpose/general, nephrostomy, and biliary drainage.
  • Micro Access Kits: Provides interventional physicians with a smaller introducer system for conducting minimally invasive procedures.
  • VenaCure EVLT System: Utilized in endovascular laser procedures to treat superficial venous disease, showcasing the company's commitment to vascular health.
  • Solero MTA System: Comprising the Solero microwave generator and specially designed Solero MW applicators, this system targets microwave thermal ablation processes.

Contact Information

Address: 14 Plaza Drive
Phone: 518 795 1400